Biocon Gets USFDA Observations for Bengaluru API Facility

Sep 28, 2024 17:49

Biocon's Bengaluru-based API facility received four observations from the USFDA following an inspection. The company plans to address the observations within the stipulated time.

Photograph: Kind courtesy Biocon

New Delhi, Sep 28 (PTI) Biocon on Saturday said the US health regulator has issued four observations after inspecting its Bengaluru-based API (active pharmaceutical ingredient) facility.

The US Food and Drug Administration (USFDA) conducted a surveillance inspection of the API facility (Site 2), located at Bengaluru from September 23- 27, 2024, the company said in a regulatory filing.

"Four observations were cited at the end of the inspection, which the company will be addressing within the stipulated time," it added.

The company does not foresee any impact on the business, Biocon said.

Source: PTI

MORE NEWS

Punjab Targets 5 Lakh Acres for DSR Paddy...

Punjab aims to bring 5 lakh acres under Direct Seeding of Rice (DSR) by 2026-27 with a...

Odisha CM Visits Khurda Industrial Units

Odisha CM Mohan Charan Majhi visits industrial units in Khurda, assuring full...

Sugar Exports to US: Govt Allocates 8,606 Tonnes

India allocates 8,606 tonnes of raw cane sugar exports to the US under TRQ scheme....

BHAVYA Scheme: States Can Apply June 1

States can apply for industrial parks under the BHAVYA scheme from June 1. The scheme...

Bihar Chamber to Boost State Investment: CM

CM Choudhary says Bihar Chamber of Commerce can help maximise investment in Bihar....

NITI Aayog: Aligning Education with Economic Needs

NITI Aayog CEO urges aligning education, skilling with evolving economic needs. Focus...

Gold, Silver Price Outlook: US-Iran Talks Key

Gold and silver prices to remain rangebound amid US-Iran negotiations. Analysts eye US...

Hiring Speed vs. Background Checks: A Compromise?

Report: 57% of organizations compromise background checks for faster hiring. Credential...

Mobavenue AI: 30% Annual Revenue Growth Target

Mobavenue AI aims for 30% sustained annual revenue growth, driven by digital...

RSM US India to Expand Office Space, Sees Huge...

RSM US India plans to expand its office space in India, citing market and talent...

Biocon Gets USFDA Observations for Bengaluru API Facility

You May Like To Read

MORE NEWS